Vascular Solutions (NSDQ:VASC) exceeded Wall Street’s expectations with its 3rd-quarter earnings, sending share prices up today.
MassDevice Earnings Roundup
Bard rises on Q3 earnings beat, boosted guidance
ICU Medical’s Q3 profits plunge, founder & CEO Lopez steps aside
ICU Medical (NSDQ:ICUI) saw its 3rd-quarter profits plunge some 9.5% and announced that founder and CEO Dr. George Lopez is leaving the corner office for health reasons.
Philips Healthcare’s Q3 profits rise despite sales slump
Philips Healthcare (NYSE:PHG) managed to boost its profits by nearly 8% during the 3rd quarter, despite posting a sales slump of more than 7%.
Mazor Robotics preps public offering, releases Q3 prelims
Third-quarter revenues for Mazor Robotics (NSDQ:MZOR) are expected to slide nearly 27%, the Israeli medical device company said, adding that it’s planning an offering of up to 2.3 million shares of its stock.
GE Healthcare boosts Q3 profits despite flat sales
GE Healthcare (NYSE:GE) managed to boost its profits by more than 7% despite posting flat sales during the 3rd quarter.
Align Technology’s Q3 earnings shatter expectations
Align Technology (NSDQ:ALGN) beat its own forecast and shattered Wall Street’s earnings expectations with its 3rd-quarter results, sending shares up more than 15% this morning ahead of the market’s open.
Stryker’s Q3 profits plunge on recall costs
Danaher climbs on Q3 numbers
Baxter meets The Street with Q3 results
Abbott beats The Street despite Q3 sales miss
Abbott (NYSE:ABT) shares ticked up today ahead of the market’s open after the healthcare giant beat Wall Street’s earnings expectations despite missing its 3rd-quarter sales target.
Abbott posted profits of $966 million, or 61¢ per share, on sales of $5.37 billion for the 3 months ended Sept. 30, for a 50.3% profit slide on sales growth of 2.0% compared with Q3 2012. Analysts had expected sales of $5.77 billion.